{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:28:20Z","timestamp":1758050900093,"version":"3.44.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Scientific Technology Project of Liaoning Province","award":["2013225220"],"award-info":[{"award-number":["2013225220"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81202955"],"award-info":[{"award-number":["81202955"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.cellimm.2015.08.004","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T13:49:54Z","timestamp":1439905794000},"page":"18-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Umbilical cord blood-derived dendritic cells infected by adenovirus for SP17 expression induce antigen-specific cytotoxic T cells against NSCLC cells"],"prefix":"10.1016","volume":"298","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jichun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youhong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2012","key":"10.1016\/j.cellimm.2015.08.004_b0005","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellimm.2015.08.004_b0010","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellimm.2015.08.004_b0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.18388\/abp.2006_3379","article-title":"Nonviral transfection of human umbilical cord blood dendritic cells is feasible, but the yield of dendritic cells with transgene expression limits the application of this method in cancer immunotherapy","volume":"53","author":"Markowicz","year":"2006","journal-title":"Acta Biochim. Pol."},{"issue":"9","key":"10.1016\/j.cellimm.2015.08.004_b0020","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1182\/blood-2001-11-0136","article-title":"Role of 4-1BB (CD137) in the functional activation of cord blood CD28(\u2212)CD8(+) T cells","volume":"100","author":"Kim","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cellimm.2015.08.004_b0025","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/14653240510027154","article-title":"Cord blood transplantation in adult patients","volume":"7","author":"Tse","year":"2005","journal-title":"Cytotherapy"},{"key":"10.1016\/j.cellimm.2015.08.004_b0030","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI31205","article-title":"DC-based cancer vaccines","volume":"117","author":"Gilboa","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2015.08.004_b0035","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/j.vaccine.2011.02.027","article-title":"Dendritic cells transfected with PEG10 recombinant adenovirus elicit anti-tumor immune response in vitro and in vivo","volume":"29","author":"Peng","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2015.08.004_b0040","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1016\/j.biomaterials.2011.05.013","article-title":"Simultaneous in vivo tracking of dendritic cells and priming of an antigen-specific immune response","volume":"32","author":"Noh","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.cellimm.2015.08.004_b0045","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/j.1349-7006.2009.01303.x","article-title":"Cancer\/testis (CT) antigens: potential targets for immunotherapy","volume":"100","author":"Caballero","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cellimm.2015.08.004_b0050","first-page":"S97","article-title":"Cancer\/testis antigens for therapeutic use","volume":"14","author":"Mathieu","year":"2009","journal-title":"J. BUON"},{"key":"10.1016\/j.cellimm.2015.08.004_b0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/08830185.2011.572504","article-title":"Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer","volume":"30","author":"Mirandola","year":"2011","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2015.08.004_b0060","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/08830185.2011.569903","article-title":"Sperm protein 17: clinical relevance of a cancer\/testis antigen, from contraception to cancer immunotherapy, and beyond","volume":"30","author":"Chiriva-Internati","year":"2011","journal-title":"Int. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.cellimm.2015.08.004_b0065","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.18632\/oncotarget.2802","article-title":"Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets","volume":"6","author":"Mirandola","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellimm.2015.08.004_b0070","doi-asserted-by":"crossref","first-page":"15101","DOI":"10.1073\/pnas.2135379100","article-title":"An adenoviral vector cancer vaccine that delivers a tumor-associated antigen\/CD40-ligand fusion protein to dendritic cells","volume":"100","author":"Zhang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.cellimm.2015.08.004_b0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.intimp.2014.05.010","article-title":"Enhanced dendritic cell maturation by the B-chain of Korean mistletoe lectin (KML-B), a novel TLR4 agonist","volume":"21","author":"Kim","year":"2014","journal-title":"Int. Immunopharmacol."},{"issue":"1\u20132","key":"10.1016\/j.cellimm.2015.08.004_b0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cellimm.2014.03.020","article-title":"Enhanced antitumor immunity is elicited by adenovirus-mediated gene transfer of CCL21 and IL-15 in murine colon carcinomas","volume":"289","author":"Zhao","year":"2014","journal-title":"Cell Immunol."},{"key":"10.1016\/j.cellimm.2015.08.004_b0085","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.3816\/CLC.2008.s.002","article-title":"Unmet need in lung cancer: can vaccines bridge the gap?","volume":"9","author":"Kim","year":"2008","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.cellimm.2015.08.004_b0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/10430340050016157","article-title":"Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication","volume":"11","author":"Miller","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.cellimm.2015.08.004_b0095","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11748-008-0433-6","article-title":"Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer","volume":"57","author":"Yasumoto","year":"2009","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.cellimm.2015.08.004_b0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3121\/cmr.3.4.221","article-title":"Lung cancer immunotherapy","volume":"3","author":"Raez","year":"2005","journal-title":"Clin. Med. Res."},{"issue":"3","key":"10.1016\/j.cellimm.2015.08.004_b0105","doi-asserted-by":"crossref","first-page":"e32695","DOI":"10.1371\/journal.pone.0032695","article-title":"Strengths and weaknesses of immunotherapy for advanced non-small cell lung cancer: a meta-analysis of 12 randomized controlled trials","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cellimm.2015.08.004_b0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","article-title":"New horizons in adjuvants for vaccine development","volume":"30","author":"Reed","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cellimm.2015.08.004_b0115","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.biomaterials.2010.09.058","article-title":"In vivo efficacy of a chitosan\/IL-12 adjuvant system for protein-based vaccines","volume":"32","author":"Heffernan","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.cellimm.2015.08.004_b0120","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1158\/0008-5472.CAN-10-3487","article-title":"Enhanced efficacy of therapeutic cancer vaccines produced by co-treatment with Mycobacterium tuberculosis heparin-binding hemagglutinin, a novel TLR4 agonist","volume":"71","author":"Jung","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2015.08.004_b0125","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3858\/emm.2012.44.5.038","article-title":"The Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein, a toll-like receptor 4 agonist, enhances dendritic cell-based cancer vaccine potency","volume":"44","author":"Noh","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.cellimm.2015.08.004_b0130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nri1592","article-title":"Dendritic cells as therapeutic vaccines against cancer","volume":"5","author":"Banchereau","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2015.08.004_b0135","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00262-011-1015-5","article-title":"Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells","volume":"60","author":"Kato","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cellimm.2015.08.004_b0140","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.vaccine.2011.11.080","article-title":"Saponin-based adjuvants create a highly effective anti-tumor vaccine when combined with in situ tumor destruction","volume":"30","author":"Den Brok","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2015.08.004_b0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1042\/bj3570025","article-title":"Characterization of Sp17: a ubiquitous three domain protein that binds heparin","volume":"357","author":"Wen","year":"2001","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.cellimm.2015.08.004_b0150","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1182\/blood.V98.7.2160","article-title":"Sperm protein 17 is expressed on normal and malignant lymphocytes and promotes heparan sulfate-mediated cell\u2013cell adhesion","volume":"98","author":"Lacy","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2015.08.004_b0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1477-7827-2-57","article-title":"Association of sperm protein 17 with A-kinase anchoring protein 3 in flagella","volume":"16","author":"Lea","year":"2004","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"46","key":"10.1016\/j.cellimm.2015.08.004_b0160","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1016\/j.vaccine.2014.09.021","article-title":"Cancer immunotherapy using a potent immunodominant CTL epitope","volume":"32","author":"Song","year":"2014","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.cellimm.2015.08.004_b0165","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1016\/j.vaccine.2013.07.055","article-title":"Generation of CTL responses against pancreatic cancer in vitro using dendritic cells co-transfected with MUC4 and survivin RNA","volume":"31","author":"Chen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2015.08.004_b0170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1479-5876-8-84","article-title":"Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A\u22172402","volume":"16","author":"Baba","year":"2010","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.cellimm.2015.08.004_b0175","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3892\/ijo.2013.2044","article-title":"Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican-3-derived peptide","volume":"43","author":"Tada","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.cellimm.2015.08.004_b0180","doi-asserted-by":"crossref","first-page":"e10471","DOI":"10.1371\/journal.pone.0010471","article-title":"Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer","volume":"5","author":"Chiriva-Internati","year":"2010","journal-title":"PLoS One"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874915300101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874915300101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:53:42Z","timestamp":1757804022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874915300101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0008874915300101"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2015.08.004","relation":{},"ISSN":["0008-8749"],"issn-type":[{"type":"print","value":"0008-8749"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Umbilical cord blood-derived dendritic cells infected by adenovirus for SP17 expression induce antigen-specific cytotoxic T cells against NSCLC cells","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2015.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}